| abstract |
The invention provides orally administrable liquid dosage formulations comprising at least one cholinesterase inhibitor compound. In one embodiment, the cholinesterase inhibitor compound is donepezil, a pharmaceutically acceptable salt thereof and/or a stereoisomer thereof. The liquid dosage formulations can be solutions, emulsions, suspensions, and syrups. |